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Objective: Surgery and specifically burr hole craniostomy is the most common first
choice treatment of patients with Chronic Subdural Hematoma (CSDH). However, several
aspects of neurosurgical and peri-operative management are still a subject of research,
such as how to treat bilateral CSDH and the anesthetic approach. We aim to investigate
the effect of the surgical approach to bilateral CSDH and the effect of anesthesia modality
on outcome of CSDH patients.
Methods: We retrospectively included surgically treated CSDH patients between 2005
and 2019 in three hospitals in the Netherlands. The effect of the surgical approach to
bilateral CSDH (unilateral vs. bilateral decompression) and anesthesia modality (general
vs. local anesthesia) on outcome (complications, recurrence, and length of hospital stay
over 4 days) was studied with logistic regression adjusting for potentially confounding
radiological and clinical characteristics.
Results: Data of 1,029 consecutive patients were analyzed, mean age was 73.5 years
(±11) and 75% of patients were male. Bilateral CSDH is independently associated with
an increased risk of recurrence within 3 months in logistic regression analysis (aOR 1.7,
95% CI: 1.1–2.5) but recurrence rate did not differ between primary bilateral or unilateral
decompression of bilateral CSDH. (15 vs. 17%, p = 0.775). Logistic regression analysis
showed that general anesthesia was independently associated with an increased risk of
complications (aOR 1.8, 95% CI: 1.0–3.3) and with a length of hospital admission of over
4 days (aOR 8.4, 95% CI: 5.6–12.4).
Conclusions: Bilateral CSDH is independently associated with higher recurrence rates.
As recurrence rates in bilateral CSDH are similar for different surgical approaches, the
optimal choice for primary bilateral decompression of bilateral CSDH could vary per
patient. General anesthesia for surgical treatment of CSDH is associated with higher
complication rates and longer hospital admission.
Keywords: chronic subdural hematoma, neurosurgery, anesthesia, bilateral chronic subdural hematoma, logistic
regression
Blaauw et al. Neurosurgical Management of Chronic Subdural Hematoma
INTRODUCTION
Chronic subdural hematoma (CSDH) is one of the most
frequent neurosurgical diseases with an incidence of about
17/100,000/year, increasing with age (1). CSDH is often regarded
as a benign, easily treatable disorder, but recurrence rates vary
between 10 and 15% and mortality can be as high as 27% (2).
The most commonly reported risk factors for CSDH are: older
age, use of anticoagulants, male sex, alcoholism, and a history of
direct or indirect head trauma (3, 4). Although surgical treatment
remains first choice, conservative treatment modalities are more
and more implemented in daily clinical practice (5). The optimal
surgical technique has been studied extensively (6–8), resulting
in burr hole craniostomy (BHC) with (subdural) drainage being
the preferable method (5, 9–11). Other aspects of neurosurgical
and perioperative management of CSDH are less well studied and
evidence is still lacking. In this study, we focus on two specific
neurosurgical and perioperative aspects of CSDH treatment on
which uncertainty exists; the surgical approach to bilateral CSDH
and type of anesthesia modality.
There is no consensus about the optimal surgical approach of
bilateral CSDH, even though about 25% of CSDH is bilateral at
presentation (12, 13). Reports on recurrence rates of bilateral and
unilateral decompressed bilateral CSDH vary, and some studies
have shown a beneficial effect of primary bilateral decompression
in bilateral CSDH (10, 13, 14). However, currently the choice
of unilateral or bilateral decompression mainly depends on
lateralizing of symptoms and hematoma characteristics (13, 15).
Studies that have reported a benefit from primary bilateral
decompression suggest that the recurrence is related to a decrease
in intracranial pressure after unilateral decompression and
subsequent shift of the brain toward the operated side (13). Both
factors might lead to an increase of the contralateral subdural
space and subsequent expansion of the contralateral hematoma,
rather than actual recurrence.
To address the uncertainties concerning the surgical approach
of bilateral CSDH, we compare recurrence rates in bilateral and
unilateral CSDH, assess the possible beneficial effect of primary
bilateral decompression and study the factors associated with
choice for side of decompression. We hypothesize that there is
a beneficial effect of primary bilateral decompression in reducing
the recurrence rate of bilateral CSDH.
The choice of the optimal anesthesia modality is an important
aspect of perioperative and neurosurgical management of CSDH.
In other conditions primarily affecting elderly patients, the
benefits of localized anesthesia (LA) over general anesthesia (GA)
has been reported (16). For CSDH only limited studies on this
subject exist. Studies that have assessed the differences between
LA and GA in CSDH, report beneficial effects of LA (17, 18).
Despite this finding, a recent large prospective study showed that
93% of CSDH patients is treated with GA (10).
Abbreviations: ASA, Acetylsalicylic acid; BHC, Burr-hole craniostomy; CCI,
Charlson comorbidity index; CSDH, Chronic Subdural Hematoma; DOAC, Direct
Oral Anticoagulants; GA, General anesthesia; GCS, Glasgow Coma Scale; LA,
Local anesthesia; MGS, Markwalder Grading Scale; VKA, Vitamin- K antagonist.
We hypothesize that there is a beneficial effect of primary
bilateral decompression compared to unilateral decompression
on recurrence of bilateral CSDH and that LA compared to GA
reduces postoperative complication rates and lowers length of
hospital stay for patients with CSDH.
METHODS
We retrospectively collected data of all consecutive CSDH
patients that were treated in three Neurosurgical centers in
the Netherlands between 2005 and 2019. The inclusion period
per center varied, based on the availability of patient data
caused by transitions from paper to electronical patient files,
from eight to thirteen years. We identified patients based on
the codes registered for diagnosis, treatment and operation.
Exclusion criteria were: Age under 18 years and acute subdural
hematomas, defined as a SDH consisting of more than 1/3rd
hyperdense components. Furthermore, patients with ventriculo-
peritoneal shunts, patients with a history of intracerebral tumor
or arteriovenous malformation prior to CSDH diagnosis were
excluded as well as all patients who did not receive surgical
treatment for their CSDH. The study was approved by the local
ethical committees of the three neurosurgical centers. As all the
data had been collected for routine clinical care, the necessity of
informed consent was waived for this retrospective study.
We recorded side hematoma and of operation, together
with anesthesia modality. Specifically we compared unilateral
vs. bilateral decompression in patients with bilateral CSDH and
general vs. local anesthesia.
Clinical and demographic data that were recorded included
age, sex, comorbidity, medication use, hospital of treatment, and
length of hospital stay. Additionally, we collected data on clinical
severity measured by Markwalder Grading Scale (19) (MGS) and
Glasgow Coma Scale (GCS)and on admission. Comorbidities at
time of diagnosis were measured with the Charlson Comorbidity
Index (CCI) (20).
Preoperative data included CT data comprising hematoma
characteristics, such as type [classification of Nakaguchi et al.
(21)] side of hematoma, maximal hematoma thickness in the
axial plane (in centimetres) and midline shift (in millimetres).
Outcomes were complications, recurrence and length of
hospital stay. Recurrence was defined as a return of clinical
symptoms and reaccumulation of the CSDH on imaging (CT-
scan), requiring retreatment (of the hematoma) within three
months from the initial diagnosis. Postoperative complications
included delirious state, rebleeding, wound infection, seizures,
and systemic infection and were scored to be either present
or absent. Due to low numbers of individual postoperative
complications, complications were grouped and dichotomized
into present or absent. Length of hospital stay was dichotomized
at the median of 4 days.
Statistical Analysis
Baseline characteristics and outcomes were compared between
intervention groups (unilateral vs. bilateral and local vs. general
anesthesia) either with χ2 tests or Mann-Whitney U-test,
depending on the type of the variable.
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In multivariable binary logistic regression we tested the
association of intervention group with outcome, adjusted for the
potential confounders (age, sex, CCI, and MGS at presentation).
Additionally, since length of stay and complications are
correlated, we adjusted for length of hospital stay in the models
for complications and for complications in the model for length
of hospital stay. Finally for local vs. general anesthesia, we also
adjusted for location of treatment (which hospital).
RESULTS
Patient characteristics
We included a total of 1,029 patients, of whom 773 were men
(75%). The mean age was 74 years (±11) (Table 1). A history of
head traumawas present in 571 patients (55%).Most patients had
a MGS of 1 or 2 (respectively, 32 and 64%) with a median GCS
score of 15 (IQR: 1).
Regarding CSDH characteristics, 772 (75%) of patients had
a unilateral hematoma and bilateral CSDH was present in
257 patients (25%). Antiplatelet therapy was used by 247
patients (24%) and 324 patients (32%) used oral anticoagulants.
Acetylsalicylic acid (ASA) and Vitamin K Antagonists (VKA)
were most often used, in 176 (71%) and 310 (96%), respectively.
Most common hematoma types were hypodense, isodense,
and trabecular. As for surgical technique, BHC was applied in
995 patients (96%). Localized anesthesia was performed in 609
patients (66%). The median length of hospital stay was 4 days
(IQR 8). A total of 117 postoperative complications occurred
in 111 patients (11%). The most often seen complications were
delirious state, pneumencephalus, empyema, or wound infection
and seizures. Recurrence within 3 months of diagnosis occurred
in 115 patients (11 %) and 40 patients died within three
months (4%).
Neurosurgical Centers
The data of three neurosurgical centers was used for this study.
The majority of patients, 641 (62%) was treated in Center 1
(Table 2). The surgical technique used for drainage of CSH was
similar in all three centers, i.e., burr-hole drainage in respectively,
99, 94, and 93% of patients with per-operative flushing/ irrigation
of the hematoma compartment with saline. Median time of post-
surgery drainage was 24 h in center 1 and 48 h in center 2 and 3.
In center 2, a relatively high number of patients, 22 (15%) did
not receive post-surgery drainage. In center 1, local anesthesia
was applied in 587 (92%) of patients, whereas center 2 and 3
applied local anesthesia in, respectively, 2 (3%) and 20 (6%) of
their patients.
Bilateral CSDH
The recurrence rate in bilateral CSDH (40 patients, 16%) was
significantly higher than in unilateral CSDH (75 patients, 10%)
patients (p = 0.01). No differences were present in sex (p =
0.279), age (p = 0.555), MGS at admission (p = 0.279), CCI at
diagnosis (p= 0.524) or three-month mortality rates (p= 0.139)
(Table 3). In multivariable analysis, patients with bilateral CSDH
were more likely to develop recurrence than those with unilateral
TABLE 1 | General characteristics of 1,029 surgically treated CSDH patients.
Variables Patients, N (%)
Sex
- Male 773 (75)
- Female 256 (25)
Age (mean ± SD) 73.5 (± 11)
Head trauma prior to CSDH 571 (55)
No/does not recall 256 (45)
MGS score at presentation:
MGS 0: 4 (0.4)
MGS 1: 326 (32)
MGS 2: 648 (64)
MGS 3: 31 (3)
MGS 4: 3 (0.3)
Unknown 17 (1.7)
GCS at presentation, median (IQR) 15 (1)
Side of hematoma
- Unilateral 772 (75)
- Bilateral 257 (25)
Use of Antithrombotic drugs:
- None 436 (43)
- Antiplatelet therapy 247 (24)
- Anticoagulants 324 (32)
- Other 18 (1)
- Unknown 4 (0.4)
Type of antiplatelet therapy
- Acetylsalicylic acid 176 (71)
- Clopidogrel 19 (8)
- Dual therapy 52 (21)
Type of anticoagulants
- VKA 310 (96)





- Hyperdense 34 (3) 36 (4)
- Isodense 131 (13) 129 (13)
- Separated 58 (6) 54 (5)
- Gradation 43 (4) 41 (4)
- Laminar 40 (4) 32 (3)
- Trabecular 145 (14) 121 (12)
- Hypodense 105 (10) 82 (8)
- Unknown 125 (12) 110 (11)
Hematoma thickness, cm (mean ± SD) Left: 1.8 (± 0.7) Right: 1.8 (±
0.7)







- Local 609 (66)
- General 314 (34)
- Unknown 106 (10)
(Continued)
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TABLE 1 | Continued
Variables Patients, N (%)
Length of hospital stay, days median
(mean, range)
4 (8, 0–76)
Postoperative complications 117 in 111
patients (11)
Type of postoperative complication
- Delirious state 34 (29)
- Pneumencephalus 22 (18)
- Empyema/wound infection 15 (13)
- Seizures 14 (12)
- Bleeding of operation wound 11 (9)
- Systemic infection 8 (7)
- Thrombosis /embolism 4 (3)




Recurrence < 3 months 115 (11)
Mortality < 3 months 40 (4)
*Including bilateral hematomas.











Treated with Burr hole craniostomy N (%) 634 (99) 65 (94) 296 (93)
Hours of post-surgery drainage (median) 24 48 48
No post-surgery drainage N (%) 14 (2) 15 (22%) 7 (2)
Local Anesthesia applied N (%) 587 (92) 2 (3) 20 (6)
CSDH, after adjusting for age, sex, MGS, and CCI at admission.
(aOR 1.7, 95% CI: 1.1–2.5)
We found no differences in recurrence rates between
bilateral CSDH patients who underwent primary unilateral
decompression (18 patients, 17%) and those who underwent
bilateral decompression (22 patients, 15%, p = 0.77) (Table 4).
Also, there was no statistically significant difference in hematoma
thickness between patients with bilateral (2.9 cm. ± 0.8) and
unilateral CSDH (3.0 ± 0.9, p = 0.057). Preoperative midline
shift was found to be significantly larger in unilaterally treated
bilateral CSDH (7.5 vs. 5.6mm, p = 0.001). MGS at presentation
did not differ (p = 0.66). We did find that in 50% (9 of 18) of
the primary unilateral decompressed bCSDH with recurrence,
the contralateral side was operated (Figure 1).
Local vs. Generalized Anesthesia
Anesthesia modality was known in 923 patients. The number of
postoperative complications was significantly higher in general
anesthesia (52 cases, 17%) than in local (50 cases, 8%) (p= 0.000)
(Table 5) Median length of hospital stay was significantly longer
in general anesthesia (8 days, IQR 8) than in local (3 days, IQR:3)










- Male 573 (74) 200 (78)
- Female 199 (26) 57 (22)




MGS 0: 4 (0.5) 0 (0)
MGS 1: 247 (32) 79 (31)
MGS 2: 486 (63) 162 (63)
MGS 3: 21 (3) 10 (4)
MGS 4: 1 (0.1) 2 (1)
Missing 13 (2) 4 (1)
Charlson comorbidity index 0.5241
CCI : 0 20 (3) 4 (2)
CCI: 1 42 (5) 10 (4)
CCI: 2 95 (12) 28 (11)
CCI: 3 177 (23) 49 (19)
CCI: 4 191 (25) 69 (27)
CCI: 5 116 (15) 47 (18)
CCI: 6 or more 128 (17) 45 (18)
Missing 3 (0.4) 5 (2)
Recurrence < 3 months 75 (10) 40 (16) 0.0121
Mortality < 3 months 26 (3) 14 (5) 0.1391
1analyzed with χ2 test; 2analyzed with Mann Whitney U-test.
TABLE 4 | Statistics of differences between unilaterally or bilaterally primary










Recurrence < 3 months 18 (17) 22 (15) 0.7711
Hematoma thickness, cm
(mean ± SD)
2.9 ± 0.8 3.0 ± 0.9 0.0572
MGS score at presentation: 0.6591
MGS 0: 0 (0) 0 (0)
MGS 1: 30 (28) 47 (32)
MGS 2: 73 (67) 88 (61)
MGS 3: 3 (3) 7 (5)
MGS 4: 1 (1) 1 (1)
Missing 2 (2) 2 (1)
Midline shift, mm (mean ±
SD)
7.5 ± 3.8 5.6 ± 3.0 0.0012
Number of bilateral CSDH patients with known side of primary decompression n = 254.
1analyzed with χ2 test; 2analyzed with Mann Whitney U test.
(p = 0.000)and MGS and CCI at admission significantly differed
between the groups (respective p-values 0.000 and 0.035). Age
(p = 0.468) and sex (p = 0.085) were not significantly different.
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FIGURE 1 | Numbers of contralateral decompression in bilateral CSDH with recurrence. *side of secondary hematoma requiring decompression is unknown in one
patient.
Also, no significant differences in three-month recurrence
rates (12 vs. 10%, p = 0.510) and three-month mortality
(4 vs. 3%, p = 0.324) between local and general anesthesia
were present.
In multivariable analysis, patients who received general
anesthesia were 1.8 times more likely to develop postoperative
complications than those receiving local anesthesia. (aOR 1.8,
95% CI: 1.0–3.3) (Table 6). After adjusting for hospital of
treatment, this relationship was no longer present. (aOR 1.7, 95%
CI: 0.7–4.0) (Table 7).
401 patients (51%) had a length of stay of 4 days or less, and
390 patients (49%) stayed 5 days or more. Patients who received
general anesthesia were 8.1 times more likely to have a length of
stay of more than four days. (95% CI: 5.6–12.1) (Table 6). When
adjusted for hospital of treatment, this association was lower, but
still present. (aOR 3.0 95% CI: 1.6–5.6) (Table 7).
DISCUSSION
In this large retrospective study, one of the largest to date,
an independently higher chance of recurrence was found
in patients with bilateral CSDH compared to patients with
unilateral CSDH. However, a beneficial effect of primary bilateral
decompression on reducing recurrence rates in bilateral CSDH,
as we hypothesized was not found. Even though no significant
differences were present, the number of unilateral treated
patients that required secondary contralateral surgery for their
recurrence, was high: about half of all patients. This increased
chance of recurrence combined with the high number of
contralateral treatments for recurrence do suggest that bilateral
CSDH requires other treatment strategies, as is proposed by other
authors (13).
The contrast of our results with the findings of a recent
study stating that there is a beneficial effect of primary bilateral
decompression, can be explained by the overall higher incidence
of recurrence in their study (13). The authors do not provide an
explanation for their high incidence of recurrence, but it could
be related to the large number of patients not receiving subdural
drainage, which is a risk factor for recurrence (6). In their study,
patients that received conservative treatment were also included,
opposed to our patients who all underwent surgery. Interestingly,
they report a high number of primary craniotomies, which has
been related to lower recurrence rates (22). In the literature the
consensus is to reserve craniotomy for solid hematomas with
multiple recurrences (23). It is debatable whether contralateral
recurrence in bilateral CSDH should be considered as secondary
hematoma growth rather than recurrence, however we classified
it as recurrence in our study. This allowed us to compare our
results with other studies, which also consider contralateral
growth in bilateral CSDH as “recurrence” (13, 14).
Another important question was the type of anaesthesia
that was used. Our study showed that general anesthesia is
independently associated with higher odds of postoperative
complications and prolonged hospitalization in patients with
CSDH. However, this association decreased when adjusted
for the hospital in which the surgery was performed. This
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Sex (male) 464 (76) 232 (74) 0.4681
Age (mean + SD) 74 (10.7) 73 (11.4) 0.0852
MGS at admission 0.0001
MGS 0: 2 (0) 2 (0)
MGS 1: 121 (20) 147 (47)
MGS 2: 470 (77) 140 (45)
MGS 3: 15 (3) 15 (5)
MGS 4: 0 (0) 3 (1)
Missing 1 (0) 7 (2)
Charlson comorbidity index 0.0351
CCI : 0 10 (2) 11 (4)
CCI: 1 32 (5) 13 (4)
CCI: 2 68 (11) 42 (13)
CCI: 3 152 (25) 57 (18)
CCI: 4 161 (26) 72 (23)
CCI: 5 96 (16) 53 (17)
CCI: 6 or more 88 (15) 62 (20)
Missing 2 (0) 4 (1)
Length of hospital stay in days
median (mean, range)
3 (5, 0-40) 8 (8, 1-76) 0.0002
Postoperative complication N (%) 50 (8) 52 (17) 0.0001
Recurrence < 3 months N (%) 72 (12) 32 (10) 0.5101
Mortality < 3 months N (%) 26 (4) 10 (3) 0.4771
Number of patients with known anesthesia modality N = 923.
1analyzed χ2 test; 2analyzed with Mann Whitney U test.
TABLE 6 | Relation between general anesthesia and postoperative complication




Length of hospital stay
five days or more aOR
(95% CI)2
General anesthesia 1.8 (1.0–3.3) 8.1 (5.4–12.1)
1Adjusted for age, sex, MGS at admission, Charlson comorbidity index, and length of
hospital stay.
2Adjusted for age, sex, MGS at admission, Charlson comorbidity index and occurrence
of postoperative complication.
is probably related to the fact that the vast majority of
patients with local anesthesia (92%) was operated in only
one of the three included neurosurgical facilities. There was
no difference in (co)morbidity or clinical severity of patients
between the hospitals, meaning that the reported differences
in hospital stay and postoperative complications are not due
to a selection bias. The skewed distribution was caused
by the standard procedures of the neurosurgical facilities.
For example in center 1, where the vast majority of LA
is applied, CSDH patients are always operated under LA
unless they are not cooperative or otherwise not having
TABLE 7 | Relation between general anesthesia and postoperative complication




Length of hospital stay
five days or more aOR
(95% CI)2
General anesthesia 1.7 (0.7–4.0) 3.0 (1.6–5.6)
1Adjusted for age, sex, MGS at admission, Charlson comorbidity index, length of hospital
stay and treatment hospital.
2Adjusted for age, sex, MGS at admission, Charlson comorbidity index, occurrence of
postoperative complication and treatment hospital.
a healthy condition for LA. Contradictory, the other two
neurosurgical facilities apply GA as part of their standard
procedure and only perform surgery under LA if patient
characteristics require so. However, in center 2, a relatively
high percentage of patients was treated without application of
a subdural drain for post-surgery drainage. This might explain
the decreased relationships of anesthesia type with postoperative
complications and length of hospital stay, after adjusting for
hospital of treatment, where the use of subdural drainage is
reported to diminish recurrence and therefore possibly reduces
complications (24).
In the current literature, limited numbers of studies have
been performed to investigate the difference between LA and
GA in CSDH. A recent review article concluded that ‘For now,
the anesthetist and surgeon, in consultation with the patient,
must decide which anesthetic technique to use on an individual
basis’ (25). However, some remarks can been made regarding the
studies that have been cited by these authors. In a retrospective
study including 1,000 CSDH patients, of which 919 received
LA, no difference in outcome between the types of anesthesia
was found (23). However, in this study outcome was only
defined as “good vs. bad postoperative results” based on the
MGS. Moreover, these LA patients underwent sedation with
LA, and not LA alone. Another smaller and retrospective study
reported more cardiac complications in the GA group, leading
to a longer hospital stay (17). This article is only available in
Korean, so the specific methods and possible limitations could
not be retrieved. Our number of postoperative complications
(without recurrence and death) may be perceived as being high,
but is comparable to reported numbers in other CSDH studies
(11, 26).
Not all studies share this view on the benefits of LA over
GA. Some attribute the increased numbers of postoperative
cognitive changes not to GA but to other aspects of surgery,
such as an increase in cytokines, and question the supposed
benefits of LA (27, 28). Other possible complicating factors
of LA, described in the literature comprise discomfort for the
patient and movement of patients during surgery, thereby
increasing the chance of surgical complications (28, 29).
When evaluating the majority of studies including our
own results, we would like to conclude that LA, with the
possibility to convert to GA in cases where patients are not
cooperative, seems to be the better option for treatment
of CSDH.
Frontiers in Neurology | www.frontiersin.org 6 June 2020 | Volume 11 | Article 550
Blaauw et al. Neurosurgical Management of Chronic Subdural Hematoma
Despite the interesting results, this study comprises strengths
and limitations. The strengths of our current study are a high
number of patients, with data collected in multiple neurosurgical
centers. The retrospective nature of our studymay lead to a risk of
selection bias, as only those patients who are deemed suitable or
even fit for operation are referred to neurosurgical centers. This
is partially illustrated by the low number of patients in the MGS
0, 3, and 4 groups. As a result we can mainly analyze the “milder”
MGS 1 or 2 groups, possibly leading to lower complication
and recurrence rates. The low complication numbers in our
study can also be due to the fact that patients are transferred
back to their own region quickly after surgery and consequently
not all complications are registered in the patient charts of
the neurosurgical departments. Finally, due to the observational
nature of our study, randomized data was not available, possibly
leading to confounding by indication. This is especially difficult
seeing that we compared interventions. As a result observed
and unobserved patient characteristics, e.g., CT findings, GCS,
may drive real-life clinical decisions, confounding the relation
between the intervention and the outcome. Statistical approaches
can adjust for observed confounders but not for unobserved
confounders so findings need to be interpreted with caution.
CONCLUSION
Bilateral CSDH is independently associated with higher
recurrence rates, but there is no difference in recurrence between
primary bilateral decompression and unilateral decompression.
Our study suggests a beneficial effect of local anesthesia
compared to general anesthesia. Therefore, in suitable patients,
local anesthesia may be considered over general. Our findings
regarding the optimal surgical approach in bilateral CSDH and
the benefits of local anesthesia in CSDH should be confirmed in
prospective studies.
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